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Abstract
Background: Rhizopus oryzae glucoamylase (RoGA) consists of three domains: an amino (N)-
terminal raw starch-binding domain (SBD), a glycosylated linker domain, and a carboxy (C)-terminal
catalytic domain. The 36-amino-acid linker region (residues 132–167) connects the two functional
domains, but its structural and functional roles are unclear.
Results: To characterize the linker sequences of RoGA and its involvement in protein expression,
a number of RoGA variants containing deletions and mutations were constructed and expressed in
Saccharomyces cerevisiae. Deletion analyses demonstrate that the linker region, especially within
residues 161 to 167, is required for protein expression. In addition, site-directed mutagenesis and
deglycosylation studies reveal that the linker region of RoGA contains both N- and O-linked
carbohydrate moieties, and the N-linked oligosaccharides play a major role in the formation of
active enzyme. Although the linker segment itself appears to have no ordered secondary structural
conformation, the flexible region indeed contributes to the stabilization of functional N- and C-
terminal domains.
Conclusion: Our data provide direct evidence that the length, composition, and glycosylation of
the interdomain linker play a central role in the structure and function of RoGA.
Background
Glucoamylase (1,4-α-D-glucan glucohydrolase, EC
3.2.1.3; GA) is an exohydrolase that catalyzes the release
of β-D-glucose by hydrolyzing α-1,4- and α-1,6-glucosidic
linkages at the non-reducing ends of raw or soluble
starches and related oligosaccharides [1-3]. GA has been
used in industrial processes such as the production of glu-
cose syrup and other food-processing applications [2,4].
Although many fungal species are capable of producing
GA under different growth conditions [5], the industrial
development of GA has focused only on GA from Aspergil-
lus niger (AnGA; identical to Aspergillus awamori GA) and
Rhizopus oryzae (RoGA) because of their stability and high
activity [3,6,7]. The overall domain structure of AnGA
consists of an N-terminal catalytic region and a C-termi-
nal starch-binding domain (SBD). In contrast, the organ-
ization of that of the RoGA consists of an N-terminal SBD
and a C-terminal catalytic region. The biochemical prop-
Published: 25 June 2007
BMC Biochemistry 2007, 8:9 doi:10.1186/1471-2091-8-9
Received: 9 March 2007
Accepted: 25 June 2007
This article is available from: http://www.biomedcentral.com/1471-2091/8/9
© 2007 Lin et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Biochemistry 2007, 8:9 http://www.biomedcentral.com/1471-2091/8/9
Page 2 of 12
(page number not for citation purposes)
erties of AnGA have been well characterized [2,8-16],
whereas less is known about RoGA [17,18]. This work
focuses on functional analysis of RoGA.
RoGA is synthesized as a precursor containing a typical
hydrophobic secretory signal sequence of 25 amino acids.
The mature form of RoGA is a single-chain protein com-
posed of three domains: an SBD (residues 26–131), a Thr/
Ser-rich linker region (residues 132–167), and a catalytic
domain (residues 168–604) [19]. The schematic represen-
tation of RoGA is shown in Figure 1. TheN-terminal SBD
belongs to the carbohydrate-binding module (CBM) fam-
ily 21 and shows a relatively low level of similarity to
SBDs in other starch-degrading enzymes [20-23]. The C-
terminal catalytic domain of RoGA plays an active role in
hydrolyzing starch and has a high degree of sequence sim-
ilarity to those of other fungal GAs [6]. The linker region
between these two functional domains is rich in hydroxyl-
amino acid residues, but information about its function is
quite limited [16,24,25]. In the CAZy classification based
on amino acid sequences of the catalytic domain, GAs are
classified into glycoside hydrolase (GH) family 15 [26],
and on two recently published articles [27,28], the N-ter-
minally positioned SBD (CBM21) and the C-terminally
positioned SBD (CBM20) are classified to be grouped into
a common CBM clan. However, the sequences of the
linker regions are highly variable. Comparison of the pri-
mary structures of different fungal GAs reveals that the
linker sequences vary greatly in length and composition
(Table 1).
In some fungal hydrolases, the substrate-binding and cat-
alytic domains are separated by a linker segment rich in
proline and hydroxy amino acid residues, some of which
have been shown to be involved in various functions
including enzymatic activity, stability, protein secretion,
and ligand binding [29,30]. In AnGA, the heavily O-glyc-
osylated linker domain is essential for secretion and is
responsible for enzyme stability as well as activity toward
raw starch [11,16,24]. Aside from the knowledge that the
linker region in RoGA acts as an interdomain spacer, very
little is known about this specific sequence stretch. The
linker region of RoGA contains high percentages of Thr
(44%) and Ser (16%) residues. Along with numerous
putative O-glycosylation sites, the RoGA linker also con-
tains one potential N-glycosylation site adjacent to the
catalytic domain (Asn167-Ser-Thr, Figure 1).
Here the baker's yeast, Saccharomyces cerevisiae, was used
as a host system to study the structure and function of
RoGA, with special attention to the interdomain linker
region. The effects of the linker segment with specific
length, composition, and glycosylation on the properties
of the protein expression, ligand or substrate binding,
enzyme activity and stability have been thoroughly inves-
tigated.
Results and Discussion
Expression of the full-length and deletion mutant GAs in S. 
cerevisiae
To investigate the function of the linker region of RoGA,
several constructs containing full-length, truncated or par-
tially deleted GA fragments were generated (Figure 1). All
constructs used in this study contained a leader signal
sequence of the N-terminal 25 residues of RoGA. When
the full-length GA was expressed in S. cerevisiae, secreted
enzyme activity was detected in the culture medium fol-
lowing incubation at 30°C (Figure 2A, lane 2 and 2B,
lower panel, lane 2). In contrast, removal of the interdo-
main 36-amino acid linker of RoGA (GA∆132–167) led to
generation of a mutant with no detectable secreted GA as
determined by plate assay or Western blot analysis (Figure
2A, lane 3 and 2B, lower panel, lane 3), suggesting that the
linker played an important role in the function of RoGA.
To further examine whether the linker region was essential
for the formation of active starch-binding or catalytic
domains, four deletion mutants devoid of either the sub-
strate binding or catalytic domain in the presence or
absence of the linker region were engineered to generate
plasmids pS1-GA∆168–604 encoding the SBD with the C-
terminal linker region; pS1-GA∆132–604 encoding the
SBD alone; pS1-GA∆26–131 encoding the linker region
Table 1: Amino acid sequences of the linker region from fungal GAs. Potential glycosylation sites in the linker sequences were 
predicted by the NetNGlyc and NetOGlyc programs. The predicted N-glycosylation sites are underlined and the putative O-
glycosylation sites are labeled in bold.
GA* Position (aa) Linker sequence
RoGA 132–167 SKPTTTTATTTTTTAPSTSTTTRPSSSEPATFPTGN
AnGA 494–531 ATGGTTTTATPTGSGSVTSTSKTTATASKTSTSTSSTS
HrGA 500–504 NVTSS
HgGA 490–508 SKQTPNPSAAPSPSPYPTA
McGA 129–177 SVTTTTTTAPTTTTSGGSSTTTGGSTTTATSVPTGVPSGFPTGNSTISS
NcGA 494–519 ATATATSFPANLTPASTTVTPPTQTG
*GenBank or GenPept accession numbers are as follows: Ro, Rhizopus oryzae (from Simpson Biotech); An, Aspergillus niger (AAP04499); Hr, 
Hormoconis resinae (Q03045); Hg, Humicola grisea (AAA33386); Mc, Mucor circinelloides (AAN85206); and Nc, Neurospora crassa (P14804).BMC Biochemistry 2007, 8:9 http://www.biomedcentral.com/1471-2091/8/9
Page 3 of 12
(page number not for citation purposes)
preceding the catalytic domain; and pS1-GA∆26–167
encoding the catalytic domain only. It was found that two
SBD-containing clones, one, GA∆168–604, containing
the linker sequence and the other, GA∆132–604, without
the linker sequence were both successfully expressed and
secreted (Figure 2B, upper panel, lanes 3 and 4). Since no
effect was observed in the absence of the linker in both
cases, the linker region appeared to be not essential for the
formation and secretion of the SBD. As for the catalytic
domain-containing variants, GA∆26–131 was successfully
expressed and secreted in yeast, but GA∆26–167 lacking
of the linker sequence was not expressed at all (Figure 2B,
lower panel, lanes 4 and 7), indicating that the linker
region was specifically required for formation and secre-
tion of the catalytic domain. To further define which
region in the linker was crucial for its role in facilitating
formation and secretion of the catalytic domain, several
constructs encoding partial deletions of the linker region
fused to the catalytic domain were subsequently expressed
and characterized. Interestingly, both GA∆26–145 and
GA∆26–160, unlike GA∆26–167, were successfully
expressed in secretory forms (Figure 2B, lower panel, lanes
5 and 6), indicating that the linker region from residues
161–167 was essential for in vivo folding and secretion of
the active catalytic domain. It is of interest that a recently
published article [7] on Rhizopus oryzar found a second GA
gene, amyB, lacks the N-terminal SBD. The amyB gene con-
tains the conserved residues in the catalytic domain
important for starch hydrolysis, and the gene also con-
tains a stretch of linker sequence (33 bp) preceding the
catalytic domain. This finding also indicates that the small
region of linker plays an important role in function of
RoGA.
Expression of recombinant RoGAs in Saccharomyces Figure 2
Expression of recombinant RoGAs in Saccharomy-
ces. (A) Starch plate assay for GA expression in 10 µL (A600 
= 2) S. cerevisiae cells carrying pS1 (lane 1), pS1/full-length GA 
(lane 2) and pS1/GA∆132–167 (lane 3) plasmids growth on a 
SD plate containing 0.5% soluble starch at 30°C and stained 
with 0.01% iodine solution. (B) Yeast strain was transformed 
with expression plasmids containing the full-length or mutant 
GA insert. After incubation at 30°C for 3 days, the superna-
tants were collected and concentrated. Culture supernatant 
(10 µL) from each clone was examined by Western blotting 
using anti-GA antibody. Upper panel, lane 1, vector only; lane 
2, full-length GA; lane 3, GA∆168–604 and lane 4, GA∆132–
604; lower panel, lane 1, vector only; lane 2, full-length GA; 
lane 3, GA∆132–167; lane 4, GA∆26–131; lane 5, GA∆26–
145; lane 6, GA∆26–160 and lane 7, GA∆26–167.
Schematic representation of the wild-type RoGA and various  mutant of RoGA Figure 1
Schematic representation of the wild-type RoGA and 
various mutant of RoGA. Full-length RoGA and its dele-
tion mutants were cloned into the yeast expression plasmid 
pS1. Each construct was designed to have a natural signal 
sequence (SS) for secretion. The starch-binding and catalytic 
domains and the sequence of the linker region (amino acids 
132–167) of RoGA are indicated. The residues in the linker 
which were subjected to mutagenesis are underlined. Closed 
circles indicate the potential N-linked glycosylation sites.BMC Biochemistry 2007, 8:9 http://www.biomedcentral.com/1471-2091/8/9
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Characterization of recombinant GAs
In order to characterize RoGA and to study the function of
the linker region, the recombinant proteins including full-
length GA, GA∆168–604, GA∆132–604, GA∆26–131,
GA∆26–145, and GA∆26–160 were individually
expressed in the budding yeast S. cerevisiae and were
grown in SD media at 30°C. Extracellular (secreted) pro-
teins were concentrated from culture supernatants and
purified by cation-exchange chromatography. As shown
in Figure 3A, purified full-length GA, GA∆168–604,
GA∆132–604, GA∆26–131, GA∆26–145, and GA∆26–
160 exhibited single protein bands with purity higher
than 90%. SDS-PAGE and/or mass spectrometric determi-
nation revealed that the respective molecular mass of full-
length GA, GA∆168–604, GA∆132–604, GA∆26–131,
GA∆26–145, and GA∆26–160 was approximately 78, 21,
12, 69, 60, and 56 kDa (Table 2). The differences between
the calculated and observed molecular weights ranged
from 3% to 28%, indicating that post-translational modi-
fications occurred in some of the recombinant proteins,
presumably due to differential degree of glycosylation.
There are two main types of protein glycosylation: N-gly-
cosylation and O-glycosylation. The former refers to the
attachment of oligosaccharides to a protein through the
amide of asparagine residues, whereas the latter involves
attachment of sugars to the hydroxyamino acids serine
and threonine via their hydroxyl groups [31]. Potential N-
glycosylation sites in RoGA analyzed using the on-line
prediction server NetNGlyc version 1.0 [32] revealed that
RoGA contained three putative N-linked glycosylation
consensus sites, one (Asn167-Ser-Thr) located in the linker
region and two (Asn230-Thr-Thr and Asn236-Lys-Thr) in
the catalytic domain (Figure 1). Although no specific con-
sensus sequence for O-linked glycosylation has yet been
reported [33,34], O-glycosylation may occur on any of the
Ser or Thr residues within a short peptide region [35].
Interestingly, the program NetOglyc version 3.1 [36] pre-
dicted that potential O-glycosylation sites in RoGA were
clustered only in the linker region. Of the residues in the
36-amino-acid linker region, 61% were Ser and Thr,
among which some might serve as potential sites for O-
linked glycosylation. MALDI fingerprint mass spectrum
from the tryptic digestion fragments of RoGA (data not
shown) also showed that no peptide fragment was
mapped to the linker region, presumably due to the pres-
ence of heterogeneous glycosylation within this region.
To determine how much of the molecular weight discrep-
ancy for each recombinant protein was derived from the
addition of glycosyl groups, each protein was enzymati-
cally deglycosylated by PNGase F or Jack bean α-mannosi-
dase followed by SDS-PAGE analysis. PNGase F is an
amidase that cleaves between the innermost GlcNAc and
the asparagine residue of complex N-linked oligosaccha-
rides from glycoproteins [37]. The fully glycosylated RoGA
possessed a molecular mass of 78 kDa. After removal of
N-linked carbohydrates with PNGase F, its molecular
mass was reduced to 65 kDa (Figure 3B), indicating that
RoGA produced by S. cerevisiae was highly glycosylated
and the N-linked carbohydrates contributed approxi-
mately 13 kDa to the molecular weight. Enzymatic degly-
cosylation of asparagine-linked glycans in the catalytic
domain variants GA∆26–131, GA∆26–145, and GA∆26–
160 also showed that these proteins were efficiently glyc-
osylated to various degrees (Figure 3B).
The linker sequences code for a 36 amino acid extension
at the C-terminal end of GA∆168–604, which correspond
to a molecular mass of approximately 3.5 kDa. The differ-
ence in molecular mass between GA∆168–604 and
GA∆132–604 was 8.7 kDa, implying that the linker region
contributed to the hyperglycosylation in GA∆168–604.
However, treatment of GA∆132–604 and GA∆168–604
with the N-glycan-specific PNGase F did not reduce its
apparent molecular weight; hence there seemed to be lit-
tle or no N-glycosylation on either protein (data not
shown). At present, no enzyme comparable to PNGase F
is available for removing intact O-linked sugars [38]. In
general, O-glycans are short linear oligosaccharides con-
sisting of one to five mannose residues in yeast
[24,34,39]. Therefore, α-mannosidase, an exoglycosidase
capable of removing terminal mannose, was used to treat
the recombinant proteins. If O-linked carbohydrates were
present, the overall mass of the protein would decrease
after treatment with α-mannosidase. The SBD variant
GA∆132–604 did not respond to the treatment with α-
mannosidase, such that no change was detected in the
electrophoretic mobility (Figure 3C), suggesting that no
major O-glycosylation occurred in this case. On the other
hand, a clear shift in the mobility of GA∆168–604 was
Table 2: Comparison between calculated and experimental 
molecular weights of GAs. The molecular masses were 
calculated from the deduced amino acid compositions using the 
ExPASy Molecular Biology Server. The experimental molecular 
masses were obtained from mass spectrometry or estimated 
from SDS-PAGE.
Protein Calculated 
mass (kDa)
Apparent mass (kDa) (mass 
spectrometry/SDS-PAGE)
full-length GA 62.4 ND*/78
T165A 62.4 ND*/78
N167D 62.3 ND*/76
GA∆168–604 15.2 20.7/27
GA∆132–604 11.7 12.0/14
GA∆26–131 50.7 ND*/69
GA∆26–145 49.4 59.9 to 61.1†/60
GA∆26–160 47.9 55.5 to 56.6‡/55
*ND, not determined. †GA∆26–145 displayed multiple mass spectral 
peaks ranging from 59.9 to 61.1 kDa. ‡GA∆26–160 displayed multiple 
mass spectral peaks ranging from 55.5 to 56.6 kDa.BMC Biochemistry 2007, 8:9 http://www.biomedcentral.com/1471-2091/8/9
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observed after treatment with α-mannosidase, indicating
that presence of the linker region led to a considerable
degree of modification by high-mannose-type O-glycans
(Figure 3C). Taken together, our data indicate that the
linker region of RoGA is modified by both N- and O-
linked glycosylation, but the exact positions and functions
are not clearly understood and require further investiga-
tion.
Effects of mutations in the linker region of RoGA
The minimal active linker region Ala161 to Asn167 was pre-
viously demonstrated to be extremely important for GA
function. In addition, N-terminal sequencing analysis of
the GA∆26–160 yielded the following sequence: Ala161-
Thr162-Phe163-Pro164-Xaa165-Gly166-Xaa167, where Xaa rep-
resented unidentified residues. Generally speaking, bio-
chemically modified amino acid residues were not
identifiable by regular Edman degradation; hence resi-
dues Thr165 and Asn167 were possibly modified after trans-
lation. To abolish the glycosylation and evaluate the
consequence, Thr165 and Asn167 in the linker region were
individually mutated to generate T165A and N167D,
respectively, and their effects on protein secretion and
enzymatic activity were examined at 30°C. T165A muta-
tion showed no effect on the phenotype as compared with
wild-type full-length GA (Figure 4A and 4B, upper panel,
lanes 2 and 5), while a significant decrease in GA expres-
sion and function was observed in the N167D mutant
(Figure 4A and 4B, upper panel, lane 6). Site-specific
mutation at Asn167 led to much less active GA secretion,
presumably due to either misfolding of RoGA, or faster
degradation of the nascent protein. In support of the mis-
folding hypothesis, several different methods were used to
improve the production of the mutant GA, N167D. One
evidence showed that N167D exhibited enhanced expres-
sion at 20°C (Figure 4B, lower panel, lane 6), and about
0.5 mg protein could be obtained from each liter of yeast
culture at 20°C. The activity of the N167D mutant could
also be detected directly on starch-agar plate with pro-
longed incubation at 4°C (Figure 4C, No. 6). Similar phe-
nomena were also observed for the mutants GA∆132–167
and GA∆26–167 after prolonged incubation at low tem-
perature (Figure 4C, No. 3 and No. 4).
Moreover, elimination of the N-glycosylation site at posi-
tion Asn167 (N167D) resulted in a faster relative electro-
phoretic mobility and lower apparent molecular weight
(Figure 4D), providing additional line of evidence that the
only putative N-glycosylation site in the linker region,
Asn167-Ser-Thr, was indeed modified in S. cerevisiae. The
biological function of carbohydrates in GA is not, how-
ever, completely understood, although it directs protein
folding, facilitates secretion, and enhances stability of
Aspergillus GAs [24]. In this study, we have demonstrated
that N-glycosylation at Asn167 in the linker is required for
functional expression of RoGA, whereas mutation abol-
ishing N-glycosylation in the linker, N167D, decreased
the efficiency of protein expression. Furthermore, similar
result was obtained when Asn167 was converted to Gln
(data not shown). N-linked carbohydrates play important
roles for a variety of structural and functional activities of
glycoproteins [40]. Here, we have characterized the N-gly-
cans attached to the linker region of RoGA to be important
for folding process, especially for its catalytic domain.
The starch-binding domain
The SBD, the non-catalytic module of GA that binds raw
starch [21], is found at the N terminus in RoGA and shares
Purification and deglycosylation of recombinant RoGAs Figure 3
Purification and deglycosylation of recombinant 
RoGAs. (A) Purified proteins (1 µg) obtained by cation-
exchange chromatography were subjected to electrophore-
sis on a 15% SDS-PAGE and stained with Coomassie Brilliant 
Blue R-250. Lane 1, full-length GA; lane 2, GA∆168–604; lane 
3, GA∆132–604; lane 4, GA∆26–131; lane 5, GA∆26–145 
and lane 6, GA∆26–160. (B) Protein samples were treated 
with PNGase F (250 U) and resolved by 10% SDS-PAGE. 
Symbols (+) and (-) indicate treatment with and without 
PNGase F, respectively. (C) Recombinant SBD was treated 
with Jack bean α-mannosidase and examined by 15% SDS-
PAGE. Symbols (+) and (-) indicate treatment with and with-
out Jack bean α-mannosidase, respectively.BMC Biochemistry 2007, 8:9 http://www.biomedcentral.com/1471-2091/8/9
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only 13.5% identity with that of AnGA [22]. Characteriza-
tion of the key functional groups of this domain has been
accomplished using sequence-based structure alignment
and NMR spectroscopy [22,23]. The effects of the linker
region on SBD adsorption on to insoluble starch were
thus investigated. The binding assay was conducted at pH
4.5 using insoluble corn-starch as the affinity matrix. Fig-
ure 5 showed the binding isotherms for the interaction
between corn-starch and the SBD variants (GA∆132–604
and GA∆168–604). The binding isotherms were used to
calculate binding parameters as described in the Materials
and Methods section. The Kd values for GA∆132–604 and
GA∆168–604 were determined to be 3.98 µM and 5.99
µM, respectively; and the Bmax values of GA∆132–604 and
GA∆168–604 were measured as 35.12 µmol/g and 17.24
µmol/g, respectively. It was apparent that the 106-residue
SBD, GA∆132–604, possessed stronger ligand affinity and
higher capacity than those of the 142-residue SBD,
GA∆168–604, indicating that the presence of the linker
region in the SBD construct did not increase but instead
slightly interfered with the raw starch-binding affinity.
The difference in starch binding affinity between
GA∆132–604 and GA∆168–604 might be due to higher
sugar content in the linker region or steric hindrance
caused by the linker tail. Binding of the starch-degrading
enzyme to its substrate is a critical step in starch hydrolysis
because it involves the phase transfer of a soluble enzyme
to the insoluble substrate [15]. In our case the linker
sequence influences the binding of the SBD to starch, pos-
sibly by affecting the ligand transfer process.
The catalytic domain
GA activity was assayed by measuring the reducing sugar
released from the reaction on starch. The standard assay
was performed as previously described with minor modi-
fication [17]. The specific activities of the wild-type RoGA
and the truncated mutants are listed in Table 3. Full-
length GA and GA∆26–131 exhibited similar activities,
Binding of purified SBD to corn-starch Figure 5
Binding of purified SBD to corn-starch. SBD, at differ-
ent concentrations, was allowed to adsorb to insoluble corn-
starch (1 mg) to the point of equilibrium. Protein concentra-
tions were determined by direct measurement of unbound 
protein in solution. The data shown are representative of 
three independent experiments. Symbols: GA∆132–604 
(open circle) and GA∆168–604 (open triangle).
Characterization of enzymatic function of recombinant  RoGAs Figure 4
Characterization of enzymatic function of recom-
binant RoGAs. (A) The extracellular activity of various 
recombinant GAs was tested. Lane 1, pS1 (empty vector); 
lane 2, full-length GA; lane 3, GA∆26–167; lane 4, GA∆132–
167; lane 5, T165A and lane 6, N167D. (B) Western blot 
analysis of wild-type and mutant GAs grown at 30°C (upper 
panel) and 20°C (lower panel) for 3 days. Lane 1, pS1 (empty 
vector); lane 2, full-length GA; lane 3, GA∆26–167; lane 4, 
GA∆132–167; lane 5, T165A and lane 6, N167D. (C) Starch 
plate assays of mutant GAs. No. 1, S. cerevisiae MNN10 cells 
transformed with pS1 (empty vector); No. 2, pS1-full-length 
GA; No. 3, pS1-GA∆26–167; No. 4, pS1-GA∆132–167; No. 
5, pS1-T165A and No. 6, pS1-N167D. (D) The electro-
phoretic mobilities of wild-type GA (lane 1) and N167D (lane 
2) on an 8% SDS-PAGE.BMC Biochemistry 2007, 8:9 http://www.biomedcentral.com/1471-2091/8/9
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4.58 × 103 U/µmol and 4.88 × 103 U/µmol, respectively,
indicating that the absence of the N-terminal SBD had lit-
tle or no effect on the ability to digest soluble starch.
Moreover, comparison of the activities of the three cata-
lytic domain variants GA∆26–131, GA∆26–145 and
GA∆26–160 revealed that longer size of the linker region
was correlated with enhanced catalytic activity.
Figure 6 showed the effects of temperature and pH on
enzyme activity. Regarding the thermal stability, the full-
length RoGA remained stable at 40°C for 30 min at pH 4.5
with almost 100% of its activity remained, whereas at the
same pH only approximately 35% and 5% residual activ-
ity was respectively detected at 50°C and 60°C (Figure 6,
solid curve, open square). The three catalytic domain
derivatives possessed inactivation profiles similar to that
of the full-length GA (Figure 6, solid curves), indicating
that the linker region did not contribute as much as
expected to the thermal stability. In addition, the pH sta-
bility of the full-length RoGA at 25°C was found to be
quite high over the pH range between 4.0 and 6.0, and
more than 70% and 50% of the activity remained after 2
h incubation (Tm, 25°C) at pH 3.0 and pH 8.0, respec-
tively (Figure 6, dotted curves). The truncated enzymes
showed similar trends in stability over the pH range
tested, indicating that the linker region was not crucial for
the pH stability of GA either. Our data imply that the cat-
alytic domain can function independently in terms of
digesting soluble starch and the addition of linker
sequences does not affect the thermal and pH stabilities of
the enzyme.
Structure analysis
The three-dimensional structure of RoGA is currently una-
vailable; circular dichroism spectroscopy has been widely
used to study the secondary structure, with the goal of
understanding the role of the linker in protein structure.
In this study, the far-UV spectrum of full-length RoGA dis-
played two broad minima at 208 and 222 nm, character-
istic of the presence of a mainly α-helical structure (Figure
7A, open square). The circular dichroism spectra of cata-
lytic domain variants with different linker lengths were
also indicative of a high content of helical conformation.
In addition, the spectra of GA∆26–131, GA∆26–145, and
GA∆26–160 were very similar to each other, mainly differ-
ing in absorbance intensity (Figure 7A, closed symbols).
GA∆26–131 possessed a higher fraction of ordered sec-
ondary structure than did the other mutants, suggesting
that the linker sequence might increase the stability of the
secondary structural motifs. It was thus concluded that the
linker sequences or their high degree of glycosylation
facilitated stabilization of conformation of the catalytic
domain of RoGA.
As for the SBD, Figure 7A also showed the calculated cir-
cular dichroism spectra of GA∆132–604 and GA∆168–
604 (open triangle and circle, respectively). The negative
ellipticity peak centered at 215 nm indicated that the sec-
ondary structure of the protein was predominantly β-
sheet, but the latter showed a higher β-sheet conforma-
tion content. Similar to the case for the catalytic domain
variants, the presence of the linker peptide in the recom-
binant SBD induced a substantial conformational change
to a more ordered state. In addition, the thermal denatur-
ation of GA∆132–604 and GA∆168–604 was monitored
by circular dichroism at 215 nm. Figure 7B revealed that
Effects of temperature and pH on the enzymatic activity of  RoGA Figure 6
Effects of temperature and pH on the enzymatic 
activity of RoGA. The effect of temperature on enzymatic 
activity (solid curves) was determined by pre-incubating the 
enzyme at pH 4.5 for 30 min at different temperatures and 
then assayed for residual activity. The effect of pH on GA 
activity (dotted curves) was performed in 0.1 M glycine/ace-
tate/phosphate/tris buffers at the indicated pH values at 
25°C. The activities measured without any pretreatment 
were defined as 100%. Each data point represents the aver-
age of three measurements, and error bars represent the 
S.D. Symbols: full-length GA (open square), GA∆26–131 
(closed circle), GA∆26–145 (closed triangle), and GA∆26–
160 (closed square).
Table 3: Specific activity of wild-type RoGA and truncated 
mutants. Specific enzyme activities were evaluated per 
micromole of protein.
Enzyme Specific activity (103 U/µmol)*
full-length RoGA 4.58 ± 0.16
GA∆26–131 4.88 ± 0.04
GA∆26–145 4.05 ± 0.06
GA∆26–160 3.73 ± 0.33
*The data are expressed as the means ± SD.BMC Biochemistry 2007, 8:9 http://www.biomedcentral.com/1471-2091/8/9
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the denatured state of GA∆168–604 possessed a greater
negative ellipticity at 215 nm than did GA∆132–604, sug-
gesting that the presence of linker sequence might induce
the SBD to form a more compact structure at high temper-
ature. Taken together, although the 36-amino-acid linker
alone of RoGA is predicted to be disordered, it strongly
influences the structural ordering of the independent
functional domains of RoGA.
Conclusion
Many raw starch-degrading enzymes have a modular
structure in which the functional domains are spatially
separated by linker sequences. In AnGA, the highly O-gly-
cosylated linker segment has been shown to be needed for
the efficient digestion of raw starch [24,41]. In contrast,
the raw starch-digesting α-amylase from the yeast Crypto-
coccus sp. strain S-2, lacking of a linker segment demon-
strates that the linker region is not always essential for the
discrete domains in raw starch-degrading enzymes to
retain their proper function [42]. Our present study
focuses on functional characterization of the linker region
of RoGA. The linker between the SBD and the catalytic
domain consists of 36 amino acids with several oligosac-
charides attached, and the region facilitates the formation
of functional RoGA in S. cerevisiae. The GA∆132–167 dele-
tion mutant failed to produce detectable protein at 30°C,
presumably because the distance between the two
domains was too short for them to be folded and secreted
correctly. Interestingly, prolonged incubation at low tem-
perature was allowed to synthesize the mutant, which
showed detectable activity as visualized on starch plate
(Figure 4C No. 3), indicating that low temperature might
work in concert to increase the de novo synthesis and sta-
bilize correct folding of the mutant protein. In addition,
our results show that the properties of two functional
domains are influenced by the linker region. The linker
sequence influences the substrate binding process, possi-
bly in the substrate transfer step. Analysis of the isolated
catalytic domain shows that the formation of functional
domain requires the linker region, especially the amino
acid sequences from 161 to 167. Interestingly, the single
N-glycosylation site within the linker domain, Asn167, is
demonstrated to be extremely important for the function
of RoGA. Some glycoproteins need the N-glycans during
synthesis for proper folding, sufficient for the efficient
secretion or increased stability [43-45]. In this report, we
have demonstrated that the N-linked oligomannosides in
the linker region play an important role in expression of
functional RoGA, however, the exact structures of the oli-
gosaccharides attached to the linker segment remain to be
further investigated.
Prior to our present work, no three dimensional structure
of intact RoGA has ever been reported. The catalytic
domain of RoGA shows 36% identity and 52% similarity
to that of AnGA, a functional domain with a characteristic
α-helical structure. As for the three dimensional structure
of SBD, it has been initially molecular modeled by struc-
tural bioinformatics methodology [22] and subsequently
determined by NMR spectroscopy [23]. Interestingly,
while the SBDs of RoGA and AnGA share extremely low
similarity in their primary structures, their secondary and
tertiary structures appear to be quite similar, strongly sug-
gesting that SBDs from CBM20 and CBM21 can be
grouped into a new clan with similar functional structures
[27,28]. It has been clearly demonstrated that the pres-
ence of the linker region leads to much more stable con-
Structural determination of wild-type and mutant RoGAs Figure 7
Structural determination of wild-type and mutant 
RoGAs. (A) Each circular dichroism spectrum represents an 
average of three scans. The data were recorded at 25°C and 
corrected for the baseline contribution of the buffer. Spectra 
were truncated below 200 nm because of excessive noise at 
those wavelengths. Symbols: full-length GA (open square), 
GA∆132–604 (open circle), GA∆168–604 (open triangle), 
GA∆26–131 (closed circular), GA∆26–145 (closed triangle) 
and GA∆26–160 (closed square). (B) Thermal denaturation 
curves of GA∆132–604 (open circle) and GA∆168–604 
(open triangle) were obtained by monitoring changes in ellip-
ticity at 215 nm.BMC Biochemistry 2007, 8:9 http://www.biomedcentral.com/1471-2091/8/9
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formation of the two discrete functional domains. Taken
together, our data provide several lines of direct evidence
that the linker region of RoGA plays a crucial role in terms
of holding structural integrity, enhancing structure stabil-
ity, and facilitating functional protein expression.
Methods
Strains, media, and expression plasmid
Escherichia coli TOP10F' (Invitrogen) was used for plasmid
manipulations, and the S. cerevisiae strain MNN10
(MATa,  mnn10,  leu2∆0,  his3∆1,  met15∆0,  ura3∆0) was
used for protein expression. E. coli cells were grown in
Luria-Bertani medium (1% tryptone, 0.5% yeast extract,
and 0.5% sodium chloride) at 37°C. Yeast cultures were
grown in YPD (1% yeast extract, 2% peptone, and 2% glu-
cose) or synthetic minimal (SD) medium (0.67% yeast
nitrogen base supplemented with the appropriate amino
acids and 2% fructose) at 20 or 30°C. The expression vec-
tor used in this work was pYEX-S1 (pS1, Clontech), a
yeast-E. coli shuttle vector containing the phosphoglycer-
ate kinase (PGK) promoter, the E.coli Ampr gene, and the
yeast selectable marker URA3.
Construction of the full-length RoGA construct
The full-length cDNA encoding RoGA was kindly pro-
vided by Simpson Biotech, and the set of primers F-RoGA
and R-RoGA was used to clone the RoGA gene. Both prim-
ers included an additional EcoRI site at their 5'-ends. The
sequences of all the primers used are listed in Table 4. PCR
amplification was carried out with KlenTaq-1 DNA
polymerase (Clontech). The 1.8-kb PCR product was gel-
purified and subcloned into yT&A TA cloning vector
(Yeastern Biotech) to generate a pT-RoGA plasmid, which
was further digested with EcoRI and then subcloned into
pS1 at the same enzyme site to generate a pS1-RoGA plas-
mid.
Construction of deletion mutants of RoGA
A series of deletion mutants was generated by a PCR-based
technique using the pS1-RoGA plasmid as the template.
For the C-terminal truncation clone GA∆168–604, which
lacks the catalytic domain, the template was amplified
using the primer pair F-RoGA and R-GA∆168–604. For
GA∆132–604, which lacks both the linker region and the
catalytic domain, the template was amplified using prim-
ers F-RoGA and R-GA∆132–604. The resulting PCR prod-
ucts were separated on a 1% agarose gel and subcloned
into pS1 as described above. The internal deletion clone
GA∆132–167, which lacks the entire linker sequence, was
generated by fusing an N-terminal fragment to a C-termi-
nal fragment with a two-step PCR approach. In the first
step, F-PS1 paired with R-GA∆132–167 and F-GA∆132–
167 paired with R-PS1 were used to generate PCR prod-
ucts of 516 bp and 1517 bp, respectively. The PCR prod-
ucts thus obtained shared overlapping sequences that
could anneal in a secondary PCR. In the second step, the
two first-stage PCR products were purified, combined and
reamplified together with the external primers F-PS1 and
R-PS1. The generated PCR product was subcloned into
pS1 and sequenced for confirmation. Similar technologies
were employed to obtain the other internal deletion
clones with the following primer pairs: GA∆26–131, F-
GA∆26–131 and R-GA∆26–131; GA∆26–145, F-GA∆26–
145 and R-GA∆26–145; GA∆26–160, F-GA∆26–160 and
R-GA∆26–160; GA∆26–167, F-GA∆26–167 and R-
GA∆26–167. All primer sequences are listed in Table 4.
Halo assay for GA activity
S. cerevisiae transformants were patched on YPD agar plate
containing 0.5% (w/v) soluble starch. Secreted GA activity
was detected by observing halo formation on agar plates
containing iodine solution (0.01%).
Purification of secreted proteins from S. cerevisiae
Yeast strains were transformed using the one-step trans-
formation method as described [46]. The transformed
yeast was cultivated in SD medium for 3 days at 30°C, and
the supernatant of the culture medium was concentrated
and dialyzed against 10 mM NaOAc (pH 4.5) using an
Amicon stirred-cell concentrator (Millipore) equipped
with a PM-10 membrane (10-kDa cut-off). For purifica-
tion, the concentrated sample was loaded onto a 5-mL
HiTrap SP cation-exchange column (Amersham Pharma-
cia Biotech) that was pre-equilibrated with the same
buffer used for dialysis. The column was washed with 5
Table 4: Oligonucleotide primers used for the construction of 
plasmids. Primers were used in the amplification reactions to 
generate various DNA fragments or mutations constructs.
Name Nucleotide sequence*
F-RoGA 5'-TTCGAATTCATGCAATTATTCAATTTG-3'
R-RoGA 5'-TTCGAATTCTTAAGCGGCAGGTGCACC-3'
R-GA∆168–604 5'-TTGAATTCTCAGTTACCAGTTGGGA-3'
R-GA∆132–604 5'-TTGAATTCTCATGTAGATACTTGGT-3'
F-PS1 5'-CGTAGTTTTTCAAGTTCTTAG-3'
R-PS1 5'-TCCTTACCTTCCAATAATTC-3'
F-GA∆132–167 5'-CAAGTATCTACATCTACAATCTCC-3'
R-GA∆132–167 5'-AGGAGATTGTAGATGTAGATACTTG-3'
F-GA∆26–131 5'-TTGCTTGTTTCTGCTTCCAAGCCCACTACT-3'
R-GA∆26–131 5'-AGTAGTGGGCTTGGAAGCAGAAACAAGCAA-3'
F-GA∆26–145 5'-AGAAGTAGAAGGGGCAGCAGAAACAAGCAA-3'
R-GA∆26–145 5'-TTGCTTGTTTCTGCTGCCCCTTCTACTTCT-3'
F-GA∆26–160 5'-TTGCTTGTTTCTGCTGCTACTTTCCCAACT-3'
R-GA∆26–160 5'-AGTTGGGAAAGTAGCAGCAGAAACAAGCAA-3'
F-GA∆26–167 5'-TTGCTTGTTTCTGCTTCTACAATCTCCTCA-3'
R-GA∆26–167 5'-TGAGGAGATTGTAGAAGCAGAAACAAGCAA-3'
F-T165A 5'-CCAGCTGGTAACTCTACAATCTCCTCA
R-T165A 5'-GGAGATTGTAGAGTTACCAGCTGG
F-N167D 5'-ACTGGTGACTCTACAATCTCCTCATGGATT-3'
R-N167D 5'-GGAGATTGTAGAGTCACCAGTTGGGAAAGT-3'
*Underlined letters indicate EcoRI sites. Bold letters indicate mutated 
nucleotides.BMC Biochemistry 2007, 8:9 http://www.biomedcentral.com/1471-2091/8/9
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column volumes of 10 mM NaOAc buffer and then eluted
with 10 volumes of a linear gradient of NaCl from 0 to 1
M in the same buffer at a flow rate of 2 mL/min. Fractions
in 1-mL volumes were collected, and protein peaks were
monitored by UV absorption at 280 nm. The fractions
containing the desired proteins were pooled, dialyzed,
and concentrated. The protein concentration was deter-
mined using the bicinchoninic acid (BCA) protein assay
reagent kit (Pierce), with BSA as the reference standard.
Electrophoresis and Western blot analysis
SDS-PAGE was performed according to the method of
Laemmli [47] using 10 or 15% (w/v) polyacrylamide gels.
The protein bands in the gel were revealed by staining
with Coomassie Brilliant Blue R-250. In Western blot
analysis, extra- and intra-cellular samples were separated
by SDS-PAGE and transferred electrophoretically onto
PVDF membranes. The resulting Western blots were incu-
bated with 3% BSA in TBS as the blocking solution and
probed with polyclonal anti-RoGA antibody, used at a
1:5000 dilution. The secondary antibody was the horse-
radish peroxidase-conjugated anti-rabbit IgG, diluted to
1:5000. The bound complexes were detected with ECL
reagents (ECL kit, Pierce) and exposure to X-ray film.
Mass spectrometric analysis
Molecular mass determination of the recombinant pro-
teins was performed by Liquid Chromatography/Mass
Spectrometer (LC/MS). The intact proteins (100 pmol)
were acidified with 0.1% formic acid in 50% (v/v) ace-
tonitrile, and the data were acquired over the 800–1800
m/z range under normal scan resolution. The original elec-
trospray mass spectrum with multiply charged ion series
was deconvoluted to give a mass spectrum.
N-terminal peptide sequence analysis
For N-terminal amino acid sequencing, purified protein
was separated by SDS-PAGE, and electrophoretically
transferred to a PVDF membrane. The blotted proteins
were visualized using Coomassie Brilliant Blue R-250.
After destaining, the blots were rinsed in deionized water
and air-dried. N-terminal sequencing was performed by
automated Edman degradation using an Applied Biosys-
tems model 494 Procise sequencer at the National Taiwan
University.
Deglycosylation assays
Peptide N-glycosidase F (PNGase F, New England
Biolabs) and Jack bean α-mannosidase (Sigma-Aldrich)
were used in enzymatic deglycosylation of the recom-
binant proteins according to the manufacturers' instruc-
tions. After enzymatic treatment, the samples were
separated by SDS-PAGE and stained with Coomassie Bril-
liant Blue R-250 to detect any differences in protein
migration.
Site-directed mutagenesis of amino acid residues in the 
linker
Site-directed mutagenesis was performed with a PCR-
based technique to change Thr165 to Ala and Asn167 to Asp.
The primers used were as follows: universal primers, F-PS1
and R-PS1; mutagenic primers F-T165A and R-T165A for
the Thr165→Ala substitution; and F-N167D and R-N167D
for the Asn167→Asp substitution. All primer sequences are
listed in Table 4.
Adsorption assay
The adsorption of the SBD to granular corn-starch (Sigma-
Aldrich) was performed as follows. The purified SBD-con-
taining protein at a concentration ranging from 1.0 to 7.5
µM was mixed with 1 mg of prewashed corn-starch in a
final volume of 1 mL in 10 mM NaOAc, pH 4.5. After
incubation at 25°C for 16 h, the starch was removed by
centrifugation at 16,000 g  for 3 min at 4°C, and the
amount of unbound protein remaining in the supernatant
was determined by the BCA assay. The amount of
adsorbed protein was calculated from the difference
between the initial and unbound protein concentrations.
The maximal amount of bound protein (Bmax) and the
dissociation constant (Kd) were determined by fitting to
the non-linear regression of the binding isotherms, and
the following equation was used for saturation binding
with one binding site: B = BmaxF/(Kd+F), where B (µmol)
represents the bound protein, Bmax (µmol) is the maximal
amount of bound protein, F (µmol) is the free protein in
the system, and Kd (µmol) is the equilibrium dissociation
constant. The units of calculated Bmax and Kd were con-
verted to micromoles per gram and micromolar, respec-
tively.
GA activity toward soluble starch
Substrate was prepared by boiling 1% soluble corn-starch
in 10 mM NaOAc, pH 4.5. The amount of glucose liber-
ated from the starch by enzymatic activity was determined
using the glucose oxidase/peroxidase kit (Sigma-Aldrich).
For each reaction, 50 µL of substrate solution was equili-
brated in a 37°C water bath for 5 min, and the assay was
initiated by adding 50 µL of appropriately diluted enzyme
solution. After incubation at 37°C for 5 min, 200 µL of kit
solution was added to each sample. The reaction mixtures
were incubated for 5 min at 37°C and stopped by the
addition of 200 µL of 6 M H2SO4. The absorbance was
recorded at 540 nm using a U-3310 spectrophotometer
(Hitachi). One unit of enzyme activity was defined as the
amount of enzyme that produces 1 µmol glucose/min
under the assay conditions described above.
Effect of temperature and pH on the activity of GA
Thermal stability of the enzyme was determined by pre-
incubating the purified protein for 30 min at various tem-
peratures ranging from 20 to 65°C. At time intervals, theBMC Biochemistry 2007, 8:9 http://www.biomedcentral.com/1471-2091/8/9
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residual activity was measured with the glucose assay kit
as described above. Stability of the recombinant protein at
different pH values was studied by incubating the enzyme
in various buffers with pH values ranging from 2.0 to 11.0
for 2 h and then measuring the residual GA activity. The
buffers used were 0.1 M glycine-HCl (pH 2.0, 3.0), 0.1 M
sodium acetate (pH 4.0, 5.0), 0.1 M potassium phosphate
(pH 6.0, 7.0), 0.1 M Tris-HCl (pH 8.0), and 0.1 M glycine-
NaOH (pH 9.0, 10.0, 11.0).
Circular dichroism studies
Circular dichroism measurements were carried out with
an AVIV model 202 spectropolarimeter (Aviv Associates,
Lakewood, NJ). Far-UV wavelength scans were recorded
from 200 to 260 nm with a bandwidth of 1.0 nm, using a
0.1-cm path length cuvette at 25°C. Each spectrum was an
average of three consecutive scans and was corrected by
subtracting the buffer spectrum. Thermal denaturation
experiments were performed by increasing the tempera-
ture from 25 to 96°C, allowing temperature equilibration
for 1.5 min before recording each spectrum. All of the data
are expressed in terms of mean residue ellipticity, [θ]m.r.w.,
calculated by the equation: [θ]m.r.w.  = (100θobs)/(nlc),
where θobs is the observed ellipticity in degrees, n is the
number of amino acids, l is the length of the light path in
centimeters, and c is the molar concentration of the pro-
tein.
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